1
|
Ciftci S, Safali S, Ergin M, Özdemir A, Acar MA. Is methyl methacrylate fixator reliable for the treatment of gartland type IV supracondylar fractures? Niger J Clin Pract 2023; 26:1463-1471. [PMID: 37929522 DOI: 10.4103/njcp.njcp_15_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2023]
Abstract
Background In childhood supracondylar fractures of the humerus, fixation with percutaneous Kirschner wire is the standard treatment. In the case of irreducible-unstable fractures, these can be defined as fractures in which reduction is not well-achieved or in which fixation cannot be achieved with the K-wire. Intraoperative management of these types of fractures may be difficult. Treatment with a methyl methacrylate fixator consisting of K-wire and methyl methacrylate cement, as defined by the senior author of the article, may be a good option for Gartland type IV supracondylar humeral fractures where the fracture is unstable in flexion and extension due to complete periosteal tearing. Materials and Methods The short-term and mid-term results of 27 patients between the ages of 4-12 with Gartland type IV supracondylar fracture of the humerus treated with methyl methacrylate fixation were reviewed. The patients were scored in terms of function and cosmetic satisfaction. Results A total of 19 of the 27 patients treated with the methyl methacrylate fixator had full elbow motion function and rated the outcome of the treatment as excellent, which was judged by orthopedic surgeons on the basis of Flynn's criteria. Six patients had nearly full elbow motion and evaluated their recovery outcome as good. Two patients reported nearly full range of motion (ROM) and evaluated the method as moderate in terms of treatment. Discussion Treatment with the methyl methacrylate fixation method is an inexpensive method that allows early joint mobilization, provides strong biomechanical stability, ensures good outcomes, and should be considered in the treatment of irreducible and unstable supracondylar fractures of the humerus.
Collapse
Affiliation(s)
- S Ciftci
- Department of Orthopedics and Traumatology, Selcuk University Medical Faculty, Konya, Turkey
| | - S Safali
- Department of Orthopedics and Traumatology, Selcuk University Medical Faculty, Konya, Turkey
| | - M Ergin
- Department of Orthopedics and Traumatology, Cihanbeyli State Hospital, Konya, Turkey
| | - A Özdemir
- Department of Orthopedics and Traumatology, Division of Hand Surgery, Selcuk University Medical Faculty, Konya, Turkey
| | - M A Acar
- Department of Orthopedics and Traumatology, Selcuk University Medical Faculty, Konya, Turkey
| |
Collapse
|
2
|
Özsoy Z, Özdemir A, Ekici M, Eken A, Çakmak F, Bilgin E, Kiliç L, Ertenli Aİ, Saribaş Z, Karadag O, Şener B. AB1076 IS THERE AN ADDITIONAL IMPACT OF STIMULATING CD8+ LYMPHOCYTES TO DETECT LATENT TUBERCULOSIS IN PATIENTS WITH RHEUMATIC DISEASES? Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundPurified protein derivative skin test (PPD) or interferon gamma release assays (IGRAs) are used as diagnostic tools to detect latent tuberculosis. QuantiFERON-TB Gold Plus (QFT-Plus) is a new test that detects latent tuberculosis. Antigens of Mycobacterium tuberculosis (ESAT-6 and CFP-10) are used. The test contains two tubes: TB1 and TB2. TB1 tube contains peptides of these antigens that induce CD4+T cell response while TB2 tube contains peptides designed to stimulate both CD4+ and CD8+ T cells. The amount of interferon gamma releases from those cells are determined by ELISA method. In patients with recent exposure to tuberculosis, there is an increased amount of CD8+ expression in comparison to patients with past exposure to tuberculosis.ObjectivesTo investigate the additional impact of stimulating CD8+ lymphocytes with QFT-Plus test in order to detect latent tuberculosis in patients with inflammatory rheumatic diseases.MethodsHacettepe University Rheumatology Biologic Registry Database (HURBIO) database was used in this study. QFT-Plus test of patients with rheumatoid arthritis (RA) and spondyloarthritis (SPA) between January 2018 and March 2021 during work up before biologic/targeted therapy were analysed, retrospectively. Positivity of any of tubes has been reported as QFT (+). The impact of each tube on QFT positivity is analysed.Results1480 patients (946 (64%) SPA, 534 (36%) RA) were enrolled. 957 patients were women. The median age was 45 (min-max:18-82). Totally 12.2% of patients had been reported as QFT(+). In 6% of QFT (+) patients only TB2 tube is positive (Table 1).Table 1.The impact of each tube on QFT-Plus positivityQFT-Plus test (n=1480)Negative86.2%Indeterminate1.5%PositiveOnly TB1 tube positivity8% of positively reported patients12.2% of all patientsOnly TB2 tube positivity6% of positively reported patientsTB1 and TB2 positivity86% of positively reported patientsConclusionDisease inflammatory cascades along with ongoing usage of immunosuppressive agents could affect results of QFT-plus assay in rheumatic diseases. TB2 tubes stimulating CD8(+) T lymphocytes have additional impact in detecting latent TB infection in patients with RA and SpA.Disclosure of InterestsNone declared
Collapse
|
3
|
Özsoy Z, Özdemir A, Ekici M, Bilgin E, Kiliç L, Kiraz S, Saribaş Z, Şener B, Karadag O. POS1187 DO IMMUNOSUPPRESSIVE AGENTS AFFECT IGRA TESTS IN PATIENTS WITH RHEUMATOID ARTHRITIS? Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundTuberculin skin test (PPD) or interferon gamma release assays (IGRAs) are used to detect latent tuberculosis infection. Induration of 15 mm or more is considered positive in any person whereas this cut-off is ≥5 mm for immunosuppressed individuals such as Rheumatoid arthritis. Since IGRAs are dependent on normal T-cell function, it may result in false-negatives for among RA patients due to disease itself and immunosuppressive drugs.ObjectivesWe aimed to compare IGRA results of RA patients using high dose DMARDS vs. not using any of them.MethodsTotally 534 RA patients among Hacettepe University Rheumatology Biologic Registry Database (HURBIO) database was enrolled into this study. QFT-Plus test of patients with rheumatoid arthritis (RA) between January 2018 and March 2021 during work up before biologic/targeted therapy were analysed, retrospectively. The patient group was divided into two according to the drugs have been using at the time of IGRA test. Patients using methotrexate ≥ 10 mg or leflunomide (any dose) or steroids (≥7.5 mg prednisolone) or any combination thereof were classified as the “High Dose” group. The other group consisted of patients who did not take these drug doses. Demographic characteristics, comorbidities, drugs and doses used, and hemogram, sedimentation, and CRP values of the patients were recorded. QuantiFERON test was recorded as positive, negative, indeterminate.Results353(66.1%) RA patients were in the high dose patient group and also 287(81.3%) of these patients were female, the median age was 55 years (min:19- max:82). The high dose group was older than the other group. When the two groups were compared, no statistically significant difference was found between comorbidity, and smoking (Table 1). While QFT positivity was detected in 37 (10.5%) patients in the high-dose group, it was found to be positive in 37 (20.4%) patients in the other group (p<0.001). However, there was no significant difference regarding acute phase reactants, hemogram including lymphocyte counts and IFN-gamma levels in the tubes between these two groups.Table 1.Comparison of RA patients’ groups using high-dose immunosuppressives and not using any of themHigh Dose Methotrexate or Leflunomide or Steroid (+), (%)66.1High Dose Methotrexate or Leflunomide or Steroid (-), (%)33.9P ValueFemale81.375.10.09Age, med (min-max)55 (19-82)52 (19-81)0.01Diabetes Mellitus1110.50.84Hypertension30.624.90.16Chronic Renal Failure0.300.66Chronic Obstructive Pulmonary Disease4.23.30.59Coronary Artery Disease3.76.10.20History of malignancy0.81.70.40SmokingNever4952.50.19Ever24.127.6Quit26.318.8Leukocyte,*103/mlMedian (min-max)7.6 (2.8-28.8)7.9 (3.5 – 20.8)0.26Neutrophil,*103/ml4.8 (0.2-23.0)5.0 (1.5-19.1)0.18Lymphocyte,*103/ml1.9 (0.4-5.9)1.8 (0.5-5.3)0.67Thrombocyte,*103/ml285 (117-669)285.5 (60-724)0.79Hemoglobine,g/dL12.8 (7.7-17.9)12.8 (9.3-16.6)0.41Sedimentation,mm/saat30 (2-294)28 (2-104)0.27C Reactive Protein,mg/dl1.1 (0.1-62.8)1.1 (0-20.7)0.96QuantiFERON-TB Gold-Plus (QFT-Plus)10.520.40.00Nil med (min-max)0.07 (0-2.7)0.05 (0-0.85)0.48QFT-Plus TB-1 med (min-max)1 (0->10)0.99 (0->10)0.25QFT-Plus TB-2 med (min-max)1 (0->10)1.1 (0->10)0.42Mitogen med (min-max)10 (0->10)9.5 (0->10)0.27MethotrexateNot Taking31.433.7Less than 10 mg44.266.310 mg and more24.40LeflunomideNot Taking25.8100Taking74.20HydroxychloroquineNot Taking25.240.9Taking74.859.1SulfasalazineNot Taking62.661.9Taking37.438.1SteroidsNot Taking4.219.9Less than 7.5 mg66.380.17.5 mg and more29.50ConclusionOur results confirmed a significantly lower QFT-Plus positivity in patients with RA taking methotrexate ≥ 10 mg or leflunomide (any dose) or steroids (≥7.5 mg prednisolone). Physicians should be careful in interpretation of QFT-Plus in patients with rheumatoid arthritis. Further analysis including flow cytometry analysis is required to better identifying cut-offs for immunosuppressive individuals and patients with inflammatory rheumatic diseases.Disclosure of InterestsNone declared
Collapse
|
4
|
Çukurova M, Özdemir A. The Investigation of Cognitive Functions and Clinical High Risk Status for Psychosis in First-Degree Relatives of Patients with Substance Induced Psychotic Disorder. Eur Psychiatry 2022. [PMCID: PMC9562401 DOI: 10.1192/j.eurpsy.2022.533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Introduction The etiology of substance-induced psychotic disorder (SIPD) is an important research area to study. Objectives It is aimed to investigate clinical risk status for psychosis, schizotypal features and neurocognitive functions in siblings of the patients who have been diagnosed as SIPD and who have no family history of psychotic spectrum disorder. Methods This study included 41 healthy siblings of patients who have been diagnosed as SIPD according to DSM-V and 41 healthy controls without family history of psychiatric disorders (matched on age, gender, and years of education). The data collected with sociodemographic and clinical data form, Digid Span Test, Trail Making Test A, Trail Making Test B, Verbal Fluency Test and Stroop Test, Comprehensive Assesment of At-Risk Mental States (CAARMS) and Structured Interview for Schizotypy-Revised. Results It is determined that %41.5 of siblings and %7.3 of healthy controls are in one of the clinical high risk groups for psychosis according to CAARMS. There is significant difference in Trail Making Test A error and Trail Making Test B error and correction, verbal fluency test- lexical fluency-perseveration mean scores between siblings of patients and healthy controls. ![]()
Conclusions Siblings of patients with SIPD have more schizotypal features than healthy control group and they take part more frequent in one of high risk group for psychosis. Schizotypal features are known as trait factor and show genetic predisposition. Siblings who are in high risk groups have more schizotypal features and it may point that predisposition to psychosis is more related to underlying genetic predisposition than environmental factors and social stressors. Disclosure No significant relationships.
Collapse
|
5
|
Çobanogĝlu N, Emiralioglu N, Çakır B, Sertçelik A, Yalçın E, Kiper N, Şen V, Ufuk Altıntasş D, Çokuĝraş H, Sakallı AK, Başkan A, Hepkaya E, Yazan H, Türel Ö, Yılmaz A, Ünal G, Caĝlar T, Damadoglu E, Irmak İ, Demir E, Öztürk G, Bingöl A, Başaran E, Sapan N, Aslan A, Asfuroğlu P, Harmancı K, Köse M, Hangül M, Özdemir A, Tuĝcu G, Polat SE, Özcan G, Gayretli Z, Keskin Ö, Bilgiç S, Yüksel H, Özdoĝan Ş, Topal E, Çaltepe G, Can D, Ekren PK, Kılıç M, Süleyman A, Eyüboĝlu TŞ, Cinel G, Pekcan S, Çakır E, Özcelik U, Doĝru D. P060 Factors associated with pulmonary functions of cystic fibrosis (CF) patients in the National Cystic Fibrosis Patient Registry: a retrospective cohort study. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00393-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Özdemir A, Yilmazsoy Y, Bayar Muluk N, Şencan Z, Mutlucan HM. Olfactory bulb volume in patients with normal-pressure hydrocephalus: an MRI evaluation. Clin Radiol 2021; 76:711.e17-711.e23. [PMID: 34099259 DOI: 10.1016/j.crad.2021.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 04/21/2021] [Indexed: 11/26/2022]
Abstract
AIM To investigate changes in olfactory bulb (OB) volume in patients with idiopathic normal-pressure hydrocephalus (NPH). MATERIALS AND METHODS This multicentric retrospective study included a test group of 23 patients with NPH (10 male and 13 female patients) and a control group of 27 healthy participants without hydrocephalus. The OB volume in all participants had been measured using cranial magnetic resonance imaging (MRI). In the NPH group, positivity for disproportionately enlarged subarachnoid space hydrocephalus (DESH) was also evaluated. RESULTS The OB volumes of the NPH group (R 38.29 ± 9.34 mm3 and L37.52 ± 9.59 mm3) were significantly lower than those of the control group (R 45.87 ± 7.33 mm3 and L48.41 ± 7.62 mm3) bilaterally. There were no significant differences between right and left OB volumes in the NPH group. Nine of the 23 patients were DESH positive and 14 were DESH negative. There were no significant differences between OB volumes of the DESH positive and DESH vpatients in the NPH group. In both groups, there was a positive correlation between right and left OB volumes. There were no significant correlations between OB volumes and age or gender. In the NPH group, there were no significant correlations between DESH positivity and OB volumes. CONCLUSION OB volume decrease and olfactory problems should be taken into account in idiopathic NPH patients. When expanded ventricles and decreased OB volume are observed at cranial MRI, a diagnosis of idiopathic NPH should be considered.
Collapse
Affiliation(s)
- A Özdemir
- Radiology Department, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey
| | - Y Yilmazsoy
- Radiology Department, Faculty of Medicine, Bolu Abant İzzet Baysal University, Bolu, Turkey
| | - N Bayar Muluk
- ENT Department, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey.
| | - Z Şencan
- ENT Department, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey
| | - H M Mutlucan
- Neurology Department, Bolu İzzet Baysal State Hospital, Bolu, Turkey
| |
Collapse
|
7
|
Okuroglu N, Ozturk A, Özdemir A. IS IRON DEFICIENCY A RISK FACTOR FOR THE DEVELOPMENT OF THYROID AUTOANTIBODIES IN EUTHYROID WOMEN WITH REPRODUCTIVE AGES? Acta Endocrinol (Buchar) 2020; 16:49-52. [PMID: 32685038 DOI: 10.4183/aeb.2020.49] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Contex The first trimester of pregnancy is the most sensitive period in terms of thyroid hypofunction. Iron deficiency has been associated with both thyroid function and thyroid autoimmunity. Objective We aimed to investigate whether iron deficiency is a risk factor for thyroid autoimmunity in non-pregnant women at childbearing age. Design This cross- sectional study was conducted in non-pregnant women who presented to the Internal Medicine Policlinic between January 2018 and December 2018 in the University of Health Sciences "Fatih Sultan Mehmet" Training and Research Hospital. Methods Three hundred fifty-eight non-pregnant women of reproductive ages (203 iron deficient-ID, 155 control) participated in this study. Women with known thyroid disease, currently undergoing treatment for thyroid disease or whose thyroid function tests were outside the reference range were excluded from the study. Blood sample was taken after at least 8-10 hours of fasting for measurement of serum iron (Fe), total iron binding capacity (TIBC), serum ferritin (SF), whole blood count, thyroid function tests (fT4, TSH), anti-thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin antibody (TgAb). The patients with SF levels ≤ 15 ng/dL were accepted as iron deficiency. Results The group with ID had higher TSH and lower T4 values that did not reach statistical significance compared to the control group (p=0.101 and p=0.098, respectively). Antibody positivity was more frequent in the ID group than in the control group (35.96% vs. 20.65%, p = 0.002). Conclusions Iron deficiency is associated with thyroid autoimmunity and it should be considered as a risk factor for screening thyroid antibody, particularly in pregnancy planning women.
Collapse
Affiliation(s)
- N Okuroglu
- University of Health Sciences, "Fatih Sultan Mehmet" Training and Research Hospital, Istanbul, Turkey
| | - A Ozturk
- University of Health Sciences, "Fatih Sultan Mehmet" Training and Research Hospital, Istanbul, Turkey
| | - A Özdemir
- University of Health Sciences, "Fatih Sultan Mehmet" Training and Research Hospital, Istanbul, Turkey
| |
Collapse
|
8
|
Pergel A, Tümkaya L, Çolakoğlu MK, Demiral G, Kalcan S, Özdemir A, Mercantepe T, Yilmaz A. Effects of infliximab against carbon tetrachloride-induced intestinal injury via lipid peroxidation and apoptosis. Hum Exp Toxicol 2019; 38:1275-1282. [PMID: 31378095 DOI: 10.1177/0960327119867758] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Carbon tetrachloride (CCL4) is often employed in the production of chlorofluorocarbons, petroleum refining, oil and rubber processing, and laboratory applications. Oral, subcutaneous, and inhalation exposure to CCL4 in animal studies have been shown to be capable of leading to various types of cancer (benign and malignant, liver, breast, and adrenal gland tumors). The present study also evaluated the protective role of infliximab (INF) against the deleterious effects of CCL4 on the intestinal system. Twenty-four male Sprague-Dawley rats were randomly assigned into three groups, control (n = 8), CCL4 (n = 8), and CCL4 + INF (n = 8). The control group received 1 mL isotonic saline solution only via intraperitoneal (i.p.) injection. The CCL4 group received a single i.p. dose of 2 mL/kg CCL4. The CCL4 + INF group received a single i.p. dose of 7 mg/kg INF followed 24 h later by a single dose of 2 mL/kg CCL4. All rats were euthanized 2 days following drug administration. CCL4 group samples also exhibited diffuse loss of enterocytes, vascular congestion, neutrophil infiltration, an extension of the subepithelial space and significant epithelial lifting along the length of the villi with a few denuded villous tips. In addition, CCL4 treatment increased intestinal malondialdehyde (MDA) level and caspase-3 positivity. On the other hand, INF decreased MDA levels, caspase-3 positivity, and loss of villous. Our findings suggest that CCL4 appears to exert a highly deleterious effect on the intestinal mucosa. On the other hand, INF is effective in preventing this CCL4-induced intestinal injury by reducing oxidative stress and apoptosis.
Collapse
Affiliation(s)
- A Pergel
- Department of General Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - L Tümkaya
- Department of Histology and Embryology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - M K Çolakoğlu
- Department of General Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - G Demiral
- Department of General Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - S Kalcan
- Department of General Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - A Özdemir
- Department of General Surgery, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - T Mercantepe
- Department of Histology and Embryology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| | - A Yilmaz
- Department of Medical Biochemistry, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey
| |
Collapse
|
9
|
Atasever T, Özdemir A, Öznur I, Karabacak NI, Gökçora N, Işjk S, Ünlü M, Vural G. 201Tl Scintigraphy in the Evaluation of Palpable and Nonpalpable Breast Lesions: Correlation with Mammography and Ultrasonography. Nuklearmedizin 2018. [DOI: 10.1055/s-0038-1629848] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Summary
Aim: Our goal was to determine the clinical usefulness of TI-201 to identify breast cancer in patients with suspicious breast lesions on clinical examination, and/or abnormal radiologic (mammography and/or ultrasonography) findings. Methods: TI-201 scintigraphy were performed in sixty-eight patients with 70 breast abnormalities (51 palpable, 19 nonpalpable) and compared with mammography and ultrasonography (US). Early (15 min) and late (3 h) images of the breasts were obtained following the injection of 111 MBq (3 mCi) of TI-201. Visual and semiquantitative interpretation was performed. Results: Final diagnosis confirmed 52 malignant breast lesions and 18 benign conditions. TI-201 visualized 47 of 52 (90%) overall malignant lesions. Thirty-eight of 40 (95%) palpable and 9 of 12 (75%) nonpalpable breast cancers were detected by TI-201 scintigraphy. The smallest mass lesion detected by TI-201 measured 1.5x1.0 cm. Eleven breast lesions were interpreted as indeterminate by mammography and/or sonography. TI-201 scintigraphy excluded malignancy in 7 of 8 (88%) patients with benign breast lesions interpreted as indeterminate. Five of the 18 (28%) benign breast lesions showed TI-201 uptake. None of the fibroadenoma and fibrocystic changes accumulated TI-201. TI-201 scintigraphy, mammography and ultrasonography showed 90%, 92%, 85% overall sensitivity and 72%, 56%, 61% overall specificity respectively. Twenty-one of the 28 (75%) axillary nodal metastatic sites were also detected by TI-201. In malignant and benign lesions, early and late lesion/contralateral normal side (L/N) ratios were 1.58 ± 0.38 (mean ± SD) and 1.48 ± 0.32 (p >0.05), 1.87 ± 0.65 and 1.34 ± 0.20 (p<0.05) respectively. The mean early and late L/N ratios of malignant and benign groups did not show statistical difference (p>0.05). Conclusion: Overall, TI-201 scintigraphy was the most specific of the three methods and yielded favourable results in palpable breast cancers, while it showed lower sensitivity in nonpalpable cancers and axillary metastases. Combined use of TI-201 scintigraphy with mammography and US seems to be useful in difficult cases, such as dense breasts and indeterminate breast lesions.
Collapse
|
10
|
Sancak S, Aydın H, Sargin M, Orçun A, Özdemir A, Çelik A, Sunar B, Aslan G. SERUM IRISIN LEVEL INCREASES THROUGHOUT THE GESTATIONAL PERIOD AND IT DOES NOT PLAY A ROLE IN DEVELOPMENT OF GESTATIONAL DIABETES MELLITUS. Acta Endocrinol (Buchar) 2017; 13:393-399. [PMID: 31149207 PMCID: PMC6516544 DOI: 10.4183/aeb.2017.393] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
INTRODUCTION Irisin is a recently discovered novel adipomyokine that induces an increase in total body energy expenditure, improves insulin sensitivity and glucose tolerance. It has been shown that circulating levels of irisin are low in patients with obesity, diabetes mellitus and impaired glucose tolerance. However, the information about the level of circulating irisin in gestational diabetes mellitus (GDM) is controversial. MATERIAL AND METHODS Serum irisin was measured by an ELISA in a longitudinal prospective cohort study in 221 women. There were 156 healthy pregnant and 65 women with GDM. RESULTS Circulating irisin levels were significantlly higher in the middle pregnancy compared with early pregnancy levels in healthy pregnant women and in women with GDM. Serum irisin levels were found to be lower in GDM compared to healthy pregnant women during first trimester but the difference was not observed throughout the pregnancy and it was comparable in middle pregnancy. There was a significant inverse correlation of BMI with serum irisin (r = -0.193, p = 0.004) and between HbA1c and mean glucose of OGTT with serum irisin (r =-0.377, p =0.0001) and (r = -0.147, p:0.03) in the early pregnancy of pregnant women repectively. CONCLUSIONS The present study shows that serum irisin level increases throughout the gestational period from early to middle pregnancy in women with GDM, but there is no effect of irisin on the development of GDM.
Collapse
Affiliation(s)
- S. Sancak
- Fatih Sultan Mehmet Training and Educational Hospital, Division of Endocrinology and Metabolism, Istanbul, Turkey
| | - H. Aydın
- Fatih Sultan Mehmet Training and Educational Hospital, Dept. of Endocrinology and Metabolism, Kartal Lutfi Kirdar Training and Educational Hospital, Istanbul, Turkey
| | - M. Sargin
- Fatih Sultan Mehmet Training and Educational Hospital, Diabetes Department, Istanbul, Turkey
| | - A. Orçun
- Fatih Sultan Mehmet Training and Educational Hospital, Division of Biochemistry, Istanbul, Turkey
| | - A. Özdemir
- Fatih Sultan Mehmet Training and Educational Hospital, Dept. of Internal Medicine, Istanbul, Turkey
| | - A. Çelik
- Fatih Sultan Mehmet Training and Educational Hospital, Division of Obstetrics and Gynecology, Istanbul, Turkey
| | - B. Sunar
- Fatih Sultan Mehmet Training and Educational Hospital, Division of Biochemistry, Yeditepe University Hospital, Istanbul, Turkey
| | - G. Aslan
- Fatih Sultan Mehmet Training and Educational Hospital, Dept. of Internal Medicine, Istanbul, Turkey
| |
Collapse
|
11
|
Yildizhan E, Tomruk N, Dereli M, Özdemir A, Yıldırım H, Canbek Ö. Modified Electroconvulsive Therapy in Pseudocholinesterase Deficiency: A Case Report. Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.1455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Introduction.Pseudocholinesterase (PCHE) deficiency is an inherited condition, in which recovery from anesthetic agents like succinylcholine and mivacurium is slow and complicated with prolonged paralysis of respiratory muscles in susceptible patients. Succinylcholine is used very frequently as a muscle relaxant during the procedure.Objectives.In Bakirkoy research and training hospital for psychiatric and neurological diseases, 24.310 patients were hospitalized for acute conditions and 3490 of these patients were treated with electroconvulsive therapy (ECT) in 3 years. We present a very rare case that we encountered in our practice; a severe PCHE deficiency case that could have complicated the modified ECT procedure unless necessary precautions were taken.Aims.Detection of PCHE levels of all patients eligible for ECT is part of our pre-ECT assessments procedure, and the case presented here shows the benefits of this method.Methods.The patient is a 29-year-old woman, with a 15 year history of schizophrenia. She was hospitalized for homicidal risk and refusal of treatment. Inadequate clinical response with pharmacological interventions and continuous aggressive excitations directed us to consider ECT.Results.After the detection of PCHE deficiency (PCHE level: 126 U/L), we performed the modified ECT with propophol and rocuronium instead of succinylcholine as usual. Sugammadex 100 mg was used for fastening the recovery. Response to treatment, which is recorded with positive and negative syndrome scale, was good and we completed 9 ECT sessions without complication.Conclusions.Screening for PCHE levels in the pre-ECT assessments is efficacious in order to decrease the complications of the ECT procedure.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
12
|
Aksoy Poyraz C, Özdemir A, Günay G, poyraz B, Enginkaya S, Karaçetin G, Tomruk N. Use of lithium in acute mania in adolescents. Eur Psychiatry 2016. [DOI: 10.1016/j.eurpsy.2016.01.1137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
The aim of the present study was to investigate whether the use of lithium followed recommended practice in acutely manic adolescent inpatients. This study was a 12-month retrospective review of patients with manic episode admitted to Bakırköy Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital. Length of stay, medication data, serum levels and adverse effects were recorded for patients who started lithium treatment within average of 7 days of admission (n = 52). Average length of stay was 23.63 (SD = 17.6). The maximum dose prescribed within 24 h of starting treatment was 721.15 mg (SD = 239.5). The maximum daily dose was reached in an average of 7 days to 1136.5 mg (SD = 336.4). The average time after starting treatment until the first recorded serum level was 5 days. The average serum level reached was 0.5 mEq/L (SD = 0.22), which was raised to 0.6 mEq/L (SD = 0.3) at discharge with an average daily dose of 1038.46 mg (SD = 460). In 8 admissions (15.4%), one adverse effect was recorded that could have been related to lithium treatment but adverse events did not lead to discontinuation of drug. The literature supports that rapidly attained high serum levels are associated with positive outcomes. In this current study, clinicians used a relatively slow dose titration and lower serum levels were obtained suggesting that lithium was not considered as a primary agent for treating mania. Taking advantage of lithium especially for the maintenance treatment of bipolar disorder and tolerability may have driven these findings.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
13
|
Özdemir A, İbişoğlu B, Şimay YD, Polat B, Ark M. Ouabain induces Rho-dependent rock activation and membrane blebbing in cultured endothelial cells. Mol Biol 2015. [DOI: 10.1134/s0026893315010136] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
14
|
Turan-Zitouni G, Kaplancikli ZA, Uçucu Ü, Özdemir A, Chevallet P, Tunali Y. SYNTHESIS OF SOME 2-[(BENZAZOLE-2-YL)THIO]-DIPHENYLMETHYLACETAMIDE DERIVATIVES AND THEIR ANTIMICROBIAL ACTIVITY. PHOSPHORUS SULFUR 2010. [DOI: 10.1080/10426500490474851] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- G. Turan-Zitouni
- a Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry , Eskisehir, Turkey
| | | | - Ü. Uçucu
- a Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry , Eskisehir, Turkey
| | - A. Özdemir
- a Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry , Eskisehir, Turkey
| | - P. Chevallet
- b Montpellier University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry , Montpellier, France
| | - Y. Tunali
- c Anadolu University, Faculty of Pharmacy, Department of Microbiology , Eskisehir, Turkey
| |
Collapse
|
15
|
Abstract
INTRODUCTION Insulinoma is a rare pancreatic islet cell tumour that is associated with hypoglycaemia. Diagnosis of the disease, localisation of the tumour and surgical therapy may be challenging and the aim of this study is to evaluate the problems concerning insulinoma. MATERIALS AND METHODS The surgical records of patients who were operated on for insulinoma at Hacettepe University Department of General Surgery between January 1980 and December 2006 were evaluated retrospectively. The evaluated parameters were the gender and ages of the patients with symptoms, signs, diagnostic tools and surgical methods. RESULTS Twenty-six patients were included in the study. There were 17 male and nine female patients. The median age was 34. The median diagnostic period was 285 days. Abdominal computer tomography was the most frequently used diagnostic method. A total of 15 enucleations, nine distal pancreatectomies and three pancreaticoduodenectomies were performed. Histopathologically most of the tumours were benign islet cell tumours. CONCLUSIONS There are still difficulties in the diagnosis, localisation and histopathologic evaluation of insulinoma. Appropriate pre-operative evaluation, through exploration and palpation of the pancreas during the surgery, as well as experienced centres are important to increase the success of the surgery of insulinoma.
Collapse
Affiliation(s)
- D. Karakoc
- Department of General Surgery, Hacettepe University Medical School, Ankara, Turkey
| | - A. Özdemir
- Department of General Surgery, Hacettepe University Medical School, Ankara, Turkey
| | - I. Sayek
- Department of General Surgery, Hacettepe University Medical School, Ankara, Turkey
| |
Collapse
|
16
|
Özdemir A, Varol I, Akan Z, Kütük M, Kutbay F, Özaslan M. The Fauna of Spider (Araneae) in the Nizip and Karkamis—Gaziantep (Turkey). BIOTECHNOL BIOTEC EQ 2006. [DOI: 10.1080/13102818.2006.10817308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
17
|
Mardi A, Rahimi G, Amani M, Mashoufi M, Kheirkhah M, Ghaffari NM, Pierovi T, Soleimani RJ, Vanlioglu F, Karaman Y, Bingol B, Tavmergen E, Akdogan A, Akman A, Levi R, Tavmergen GEN, Ates U, Seyhan A, Atmaca U, Ortakuz S, Ata B, Akar S, Usta T, Özdemir B, Sidal B, Yoldemir T, Gee A, Sutherland P, Bowman M, Fraser IS, Haydardedeoglu B, Bagis T, Kilicdag EB, Simsek E, Aslan E, Zeyneloglu HB, Kahyaoglu S, Turgay I, Ertas E, Yilmaz B, Var T, Batioglu S, Muftuoglu K, Tekcan C, Naki MM, Uysal A, Güzin K, Yücel N, Kanadikirik F, Kelekci S, Savan K, Kalyoncu S, Gokturk U, Oral H, Mollamahmutoglu L, Ertas IE, Mollamahmutoglu L, Kahveci S, Dogan M, Mollamahmutoglu L, Isik A, Saygili U, Gol M, Koyuncuoglu M, Uslu T, Erten O, Ciftci B, Biri A, Bozkurt N, Karabacak O, Himmetoglu O, Amir JN, Nouri M, Hascalik S, Celik O, Parlakpinar H, Mizrak B, Ozsahin M, Önder C, Gezginc K, Colakoglu M, Demir SC, Cetin MT, Kadayifci O, Güzel AB, Polat I, Yildirim G, Özdemir A, Tekirdag AI, Kizkin S, Engin-Ustun Y, Ustun Y, Ozcan C, Serbest S, Ozisik HI, Ergenoglu M, Goker ENT, Uckuyu A, Ozcimen EE, Nisanoglu O, Onal C, Akgun S, Koc S, Cebi Z, Sönmez S, Yasar L, Küpelioglu L, Bilecan S, Aygün M, Zebitay AG, Dursun P, Ötegen Ü, Bozdag G, Yarali H, Demirci F, Mun S, Eraydin E, Sadik S, Sipahi C, Bayol Ü, Sarikaya S, Garipoglu DE, Delilbasi L, Gursoy R, Engin-Ustun Y, Meydanli MM, Atmaca R, Kafkasli A, Canda MT, Kucuk M, Bagriyanik HA, Ozyurt D, Canda T, Güven MA, Tamsoy S, Kaymak O, Ozkale D, Okyay RE, Neslihanoglu R, Mollamahmutoglu L, Basaran A, Gultekin M, Saygili YE, Esinler I, Bayer U, Gunalp S, Aksu T, Gultekin M, Leventerler H, Taga S, Cetin T, Solmaz S, Dikmen N, Karalök H, Ilter E, Tufekci C, Yilmaz S, Karalök AE, Batur O, Kilicdag E, Haydardedeoglu B, Tarim E, Api M, Gültekin E, Görgen H, Cetin A, Yayla M, Özkilic T, Arikan I, Abali R, Arikan D, Bozkurt S, Demir B, Gunalp S, Erden AC, Özcan J, Yazicioglu F, Demirbas R. Endocrinology and reproductive medicine. Arch Gynecol Obstet 2005. [DOI: 10.1007/bf02954773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|